Toshio Kubo

Toshio Kubo

UNVERIFIED PROFILE

Are you Toshio Kubo?   Register this Author

Register author
Toshio Kubo

Toshio Kubo

Publications by authors named "Toshio Kubo"

Are you Toshio Kubo?   Register this Author

55Publications

963Reads

25Profile Views

Re-administration of osimertinib in osimertinib-acquired resistant non-small-cell lung cancer.

Lung Cancer 2019 Jun 6;132:54-58. Epub 2019 Apr 6.

Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.02.021DOI Listing
June 2019

Successful Treatment of Metastatic Urothelial Carcinoma after Accurate Diagnosis by Immunohistochemistry.

Acta Med Okayama 2019 Jun;73(3):279-284

Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18926/AMO/56873DOI Listing
June 2019

Effects of (-)-epigallocatechin-3-gallate on EGFR- or Fusion Gene-driven Lung Cancer Cells.

Acta Med Okayama 2017 12;71(6):505-512

Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18926/AMO/55587DOI Listing
December 2017

Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system.

Oncol Rep 2017 May 11;37(5):3100-3106. Epub 2017 Apr 11.

Department of Thoracic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2017.5567DOI Listing
May 2017

Safety and discomfort during bronchoscopy performed under sedation with fentanyl and midazolam: a prospective study.

Jpn J Clin Oncol 2016 Sep 5;46(9):871-4. Epub 2016 Jul 5.

Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Hospital, Okayama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyw083DOI Listing
September 2016

Effect of Vandetanib on Lung Tumorigenesis in Transgenic Mice Carrying an Activating Egfr Gene Mutation.

Acta Med Okayama 2016 Aug;70(4):243-53

Department of Haematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18926/AMO/54499DOI Listing
August 2016

Programmed cell death protein 1 and programmed death-ligand 1 are expressed on the surface of some small-cell lung cancer lines.

Am J Cancer Res 2015 15;5(4):1553-7. Epub 2015 Mar 15.

Department of General Internal Medicine 4, Kawasaki Medical School 2-1-80 Nakasange, Kita-ku, Okayama 700-8505, Japan.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473331PMC
June 2015

Endobronchial ultrasound-guided transbronchial biopsy with or without a guide sheath for diagnosis of lung cancer.

Respir Investig 2015 May 13;53(3):93-7. Epub 2014 Nov 13.

Department of Respiratory Medicine, Okayama University Hospital, 2-5-1 Shikata-cho, Okayama 700-8558, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.resinv.2014.10.003DOI Listing
May 2015

Phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer with activating EGFR gene mutations: the Okayama Lung Cancer Study Group Trial 1001.

J Thorac Oncol 2015 Mar;10(3):486-91

*Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan; †Department of Hematology/Oncology, Vanderbilt Vanderbilt University Medical Center, Nashville, TN; ‡Department of Respiratory Medicine, NHO Shikoku Cancer Center, Matsuyama, Japan; §Department of Respiratory Medicine, NHO Iwakuni Clinical Center, Iwakuni, Japan; ‖Department of Medical Oncology, NHO Yamaguchi-Ube Medical Center, Ube, Japan; ¶Department of Respiratory Internal Medicine, Japanese Red Cross Kobe Hospital, Kobe, Japan; #Division of Clinical Oncology, Sumitomo Besshi Hospital, Niihama, Japan; **Department of Clinical Research, NHO Yamaguchi-Ube Medical Center, Ube, Japan; ††Department of Respiratory Medicine, Japanese Red Cross Okayama Hospital, Okayama, Japan; ‡‡Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan; and §§Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000434DOI Listing
March 2015

Fatal Candida septic shock during systemic chemotherapy in lung cancer patient receiving corticosteroid replacement therapy for hypopituitarism: a case report.

Jpn J Clin Oncol 2014 May 19;44(5):501-5. Epub 2014 Mar 19.

*Department of Respiratory Medicine, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyu019DOI Listing
May 2014

Effect of AZD1480 in an epidermal growth factor receptor-driven lung cancer model.

Lung Cancer 2014 Jan 29;83(1):30-6. Epub 2013 Oct 29.

Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.10.011DOI Listing
January 2014

Afatinib prolongs survival compared with gefitinib in an epidermal growth factor receptor-driven lung cancer model.

Mol Cancer Ther 2013 May 26;12(5):589-97. Epub 2013 Feb 26.

Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-12-0885DOI Listing
May 2013

Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy.

Cancer Sci 2013 Jan 24;104(1):78-84. Epub 2012 Nov 24.

Department of Hematology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12045DOI Listing
January 2013

JAK2-related pathway induces acquired erlotinib resistance in lung cancer cells harboring an epidermal growth factor receptor-activating mutation.

Cancer Sci 2012 Oct 24;103(10):1795-802. Epub 2012 Jul 24.

Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2012.02363.xDOI Listing
October 2012

Disappearance of an activated EGFR mutation after treatment with EGFR tyrosine kinase inhibitors.

Lung Cancer 2012 Oct 25;78(1):121-4. Epub 2012 Jul 25.

Department of Respiratory Medicine, Okayama University Hospital, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2012.07.003DOI Listing
October 2012

STAT3 expression in activating EGFR-driven adenocarcinoma of the lung.

Lung Cancer 2012 Jan;75(1):24-9

Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2011.05.015DOI Listing
January 2012

Chemopreventive effects of gefitinib on nonsmoking-related lung tumorigenesis in activating epidermal growth factor receptor transgenic mice.

Cancer Res 2009 Sep 18;69(17):7088-95. Epub 2009 Aug 18.

Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-4205DOI Listing
September 2009

Efficacy of a lumbo-peritoneal shunt for meningeal carcinomatosis refractory to gefitinib treatment.

Anticancer Res 2009 Jul;29(7):2759-60

Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

View Article

Download full-text PDF

Source
July 2009

[Coinfection with Mycoplasma pneumoniae and Chlamydophila pneumoniae in a middle-aged adult].

Nihon Kokyuki Gakkai Zasshi 2007 Oct;45(10):808-11

Department of Respiratory Medicine, Okayama University School of Medicine.

View Article

Download full-text PDF

Source
October 2007